title: Plasma concentrations of sulfadoxine-pyrimethamine, mefloquine and its main metabolite after regular malaria prophylaxis for two years.
authors.affiliation: Department of Infectious Diseases, Karolinska Institute, Roslagstull Hospital, Stockholm, Sweden.
authors.forename: U
authors.initials: U
authors.lastname: Hellgren
authors.forename: V H
authors.initials: VH
authors.lastname: Angel
authors.forename: Y
authors.initials: Y
authors.lastname: Bergqvist
authors.forename: J S
authors.initials: JS
authors.lastname: Forero-Gomez
authors.forename: L
authors.initials: L
authors.lastname: Rombo
mesh_terms: D000328:Adult; D006207:Half-Life; D006801:Humans; D008288:Malaria / Q000097:blood* / Q000517:prevention & control; D008297:Male; D015767:Mefloquine / Q000097:blood*; D008875:Middle Aged; D011739:Pyrimethamine / Q000097:blood*; D013413:Sulfadoxine / Q000097:blood*; D013997:Time Factors
chemical_list: D013413:Sulfadoxine; D015767:Mefloquine; D011739:Pyrimethamine